| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Food Science (KJM, AKC, NJM, and AJS) and the School of Medical Sciences (IS, MAF, MJP, and AHT), RMIT University, Melbourne, Australia, and the School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, Australia (IS and HM).
Background: Flavonoids may be partly responsible for some health benefits, including antiinflammatory action and a decreased tendency for the blood to clot. An acute dose of flavanols and oligomeric procyanidins from cocoa powder inhibits platelet activation and function over 6 h in humans.
Objective: This study sought to evaluate whether 28 d of supplementation with cocoa flavanols and related procyanidin oligomers would modulate human platelet reactivity and primary hemostasis and reduce oxidative markers in vivo.
Design: Thirty-two healthy subjects were assigned to consume active (234 mg cocoa flavanols and procyanidins/d) or placebo (≤ 6 mg cocoa flavanols and procyanidins/d) tablets in a blinded parallel-designed study. Platelet function was determined by measuring platelet aggregation, ATP release, and expression of activation-dependent platelet antigens by using flow cytometry. Plasma was analyzed for oxidation markers and antioxidant status.
Results: Plasma concentrations of epicatechin and catechin in the active group increased by 81% and 28%, respectively, during the intervention period. The active group had significantly lower P selectin expression and significantly lower ADP-induced aggregation and collagen-induced aggregation than did the placebo group. Plasma ascorbic acid concentrations were significantly higher in the active than in the placebo group (P < 0.05), whereas plasma oxidation markers and antioxidant status did not change in either group.
Conclusions: Cocoa flavanol and procyanidin supplementation for 28 d significantly increased plasma epicatechin and catechin concentrations and significantly decreased platelet function. These data support the results of acute studies that used higher doses of cocoa flavanols and procyanidins.
Key Words: Cocoa • antioxidant • catechin • epicatechin • procyanidin • flavanols • platelet activation • P selectin • CD62P • platelet function • cardiovascular disease • polyphenols • F2-isoprostanes • thiobarbituric acid–reactive substances • TBARS
This article has been cited by other articles:
|
|
 |
|
  R. Corder Red wine, chocolate and vascular health: developing the evidence base Heart, July 1, 2008; 94(7): 821 - 823. [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Lee, N. J. Kang, M.-H. Oak, M. K. Hwang, J. H. Kim, V. B. Schini-Kerth, and H. J. Lee Cocoa procyanidins inhibit expression and activation of MMP-2 in vascular smooth muscle cells by direct inhibition of MEK and MT1-MMP activities Cardiovasc Res, July 1, 2008; 79(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W D. Crews Jr, D. W Harrison, and J. W Wright A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults Am. J. Clinical Nutrition, April 1, 2008; 87(4): 872 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Allen, L. Carson, C. Kwik-Uribe, E. M. Evans, and J. W. Erdman Jr Daily Consumption of a Dark Chocolate Containing Flavanols and Added Sterol Esters Affects Cardiovascular Risk Factors in a Normotensive Population with Elevated Cholesterol J. Nutr., April 1, 2008; 138(4): 725 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Taubert, N. Jung, and R. Roesen Cocoa Intake and Blood Pressure Reply JAMA, October 24, 2007; 298(16): 1863 - 1864. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hill, A. M. Coates, J. D. Buckley, R. Ross, F. Thielecke, and P. R.C. Howe Can EGCG Reduce Abdominal Fat in Obese Subjects? J. Am. Coll. Nutr., August 1, 2007; 26(4): 396S - 402S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Taubert, R. Roesen, and E. Schomig Effect of Cocoa and Tea Intake on Blood Pressure: A Meta-analysis Arch Intern Med, April 9, 2007; 167(7): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Alspach THE TRUTH IS OFTEN BITTERSWEET...: CHOCOLATE DOES A HEART GOOD Crit. Care Nurse, February 1, 2007; 27(1): 11 - 15. [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Kenny, C. L. Keen, H. H. Schmitz, and M. E. Gershwin Immune Effects of Cocoa Procyanidin Oligomers on Peripheral Blood Mononuclear Cells Experimental Biology and Medicine, February 1, 2007; 232(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. O'Kennedy, L. Crosbie, M. van Lieshout, J. I Broom, D. J Webb, and A. K Duttaroy Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 570 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Buijsse, E. J. M. Feskens, F. J. Kok, and D. Kromhout Cocoa intake, blood pressure, and cardiovascular mortality: the zutphen elderly study. Arch Intern Med, February 27, 2006; 166(4): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lamuela-Raventos, A. I. Romero-Perez, C. Andres-Lacueva, and A. Tornero Review: Health Effects of Cocoa Flavonoids Food Science and Technology International, June 1, 2005; 11(3): 159 - 176. [Abstract] [PDF]
|
|
|
|
|
|
V. Stangl, M. Lorenz, A. Ludwig, N. Grimbo, C. Guether, W. Sanad, S. Ziemer, P. Martus, G. Baumann, and K. Stangl The Flavonoid Phloretin Suppresses Stimulated Expression of Endothelial Adhesion Molecules and Reduces Activation of Human Platelets J. Nutr., February 1, 2005; 135(2): 172 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Williamson and C. Manach Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Halliwell, J. Rafter, and A. Jenner Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 268S - 276S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L Keen, R. R Holt, P. I Oteiza, C. G Fraga, and H. H Schmitz Cocoa antioxidants and cardiovascular health Am. J. Clinical Nutrition, January 1, 2005; 81(1): 298S - 303S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Kenny, C. L. Keen, P. Jones, H.-J. Kung, H. H. Schmitz, and M. E. Gershwin Cocoa Procyanidins Inhibit Proliferation and Angiogenic Signals in Human Dermal Microvascular Endothelial Cells Following Stimulation by Low-Level H2O2 Experimental Biology and Medicine, September 1, 2004; 229(8): 765 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Badia, E. Sacanella, J. Fernandez-Sola, J. M. Nicolas, E. Antunez, D. Rotilio, G. de Gaetano, A. Urbano-Marquez, and R. Estruch Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption Am. J. Clinical Nutrition, July 1, 2004; 80(1): 225 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Kenny, C. L. Keen, P. Jones, H.-J. Kung, H. H. Schmitz, and M. E. Gershwin Pentameric Procyanidins Isolated from Theobroma cacao Seeds Selectively Downregulate ErbB2 in Human Aortic Endothelial Cells Experimental Biology and Medicine, March 1, 2004; 229(3): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
